Market Cap 144.82B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.14
Forward PE 8.43
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 51,044,827
Avg Vol 43,589,973
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 100%
Beta 0.34
Analysts Sell
Price Target $28.70

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Conorkenny
Conorkenny Aug. 6 at 9:57 PM
Pfizer Largest Insider Buys in History 🚨 2 Directors have each purchased $1 million worth of $PFE shares, the largest insider buys in Pfizer's history 🤯 👀 $CTM $AXTI $VKTX
1 · Reply
jackofalltrade
jackofalltrade Aug. 6 at 9:48 PM
$PFE Paid Post from Pfizer The modern era for lung cancer patients. https://www.nytimes.com/paidpost/pfizer/the-modern-era-for-lung-cancer-patients.html?cmp=256791864&sid=9194834&pid=442084232&dclid=CPLw74b6jJYDFeqMWgUdvmkATQ&gad_source=7&gad_campaignid=23632797981
0 · Reply
Willieberich
Willieberich Aug. 6 at 8:38 PM
$PFE holding till it hits 50$
2 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 6 at 8:36 PM
$PFE $BNTX $MRNA THE TRUMP ADMINISTRATION IS WEIGHING AN ORDER ON AUTISM AND VACCINES
1 · Reply
Bach_A
Bach_A Aug. 6 at 8:33 PM
Gain Therapeutics (NASDAQ: $GANX ) has major upcoming catalysts centered on the clinical development of its lead allosteric small molecule candidate, rexaceract (GT-02287), targeted as a disease-modifying treatment for Parkinson’s disease. Following recent FDA clearance of its Investigational New Drug (IND) application, the company is advancing into mid-stage trials.Upcoming Pipeline MilestonesQ3 2026 (Initiation of Phase 2 Trial): Patient dosing is scheduled to begin for the placebo-controlled, dose-range-finding Phase 2 clinical trial of GT-02287 for Parkinson's disease across sites in the U.S., Australia, and Europe.Q4 2026 (Phase 1b Final Data): Final data readouts and biomarker updates from the ongoing extended Phase 1b clinical study of GT-02287 are anticipated, tracking longer-term safety, target engagement, and neurodegeneration markers. $ABBV $SNY $PFE $XBI
0 · Reply
framus_morrigan
framus_morrigan Aug. 6 at 8:33 PM
$PFE And one month later here we are ... about to face its weekly SMA200 again ... Weekly chart
0 · Reply
nimii
nimii Aug. 6 at 8:18 PM
$PFE 27 tomorrow
2 · Reply
EingeLTrade
EingeLTrade Aug. 6 at 8:05 PM
Two $PFE directors have each purchased $1M worth of shares, the largest insider buys in Pfizer's history 👀
2 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 6 at 8:05 PM
$PFE Albert you see what happens when leadership BUYS shares?
0 · Reply
dom04
dom04 Aug. 6 at 7:47 PM
$PFE breather? Or keeping up?
0 · Reply
Latest News on PFE
Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-06T13:09:00.000Z - 10 hours ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View


Pfizer price target raised to $27 from $26 at BofA

2026-08-05T10:45:23.000Z - 1 day ago

Pfizer price target raised to $27 from $26 at BofA


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 2 days ago

Pfizer Post Loss on Higher Revenue


Pfizer reports Q2 adjusted EPS 77c, consensus 68c

2026-08-04T10:52:17.000Z - 2 days ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c


Pfizer says LITFULO studies meet co-primary endpoints

2026-07-30T11:03:18.000Z - 7 days ago

Pfizer says LITFULO studies meet co-primary endpoints


FDA grants priority review for Pfizer’s Talzena plus Xtandi

2026-07-22T20:40:37.000Z - 15 days ago

FDA grants priority review for Pfizer’s Talzena plus Xtandi


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 4 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 6 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 6 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


Conorkenny
Conorkenny Aug. 6 at 9:57 PM
Pfizer Largest Insider Buys in History 🚨 2 Directors have each purchased $1 million worth of $PFE shares, the largest insider buys in Pfizer's history 🤯 👀 $CTM $AXTI $VKTX
1 · Reply
jackofalltrade
jackofalltrade Aug. 6 at 9:48 PM
$PFE Paid Post from Pfizer The modern era for lung cancer patients. https://www.nytimes.com/paidpost/pfizer/the-modern-era-for-lung-cancer-patients.html?cmp=256791864&sid=9194834&pid=442084232&dclid=CPLw74b6jJYDFeqMWgUdvmkATQ&gad_source=7&gad_campaignid=23632797981
0 · Reply
Willieberich
Willieberich Aug. 6 at 8:38 PM
$PFE holding till it hits 50$
2 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 6 at 8:36 PM
$PFE $BNTX $MRNA THE TRUMP ADMINISTRATION IS WEIGHING AN ORDER ON AUTISM AND VACCINES
1 · Reply
Bach_A
Bach_A Aug. 6 at 8:33 PM
Gain Therapeutics (NASDAQ: $GANX ) has major upcoming catalysts centered on the clinical development of its lead allosteric small molecule candidate, rexaceract (GT-02287), targeted as a disease-modifying treatment for Parkinson’s disease. Following recent FDA clearance of its Investigational New Drug (IND) application, the company is advancing into mid-stage trials.Upcoming Pipeline MilestonesQ3 2026 (Initiation of Phase 2 Trial): Patient dosing is scheduled to begin for the placebo-controlled, dose-range-finding Phase 2 clinical trial of GT-02287 for Parkinson's disease across sites in the U.S., Australia, and Europe.Q4 2026 (Phase 1b Final Data): Final data readouts and biomarker updates from the ongoing extended Phase 1b clinical study of GT-02287 are anticipated, tracking longer-term safety, target engagement, and neurodegeneration markers. $ABBV $SNY $PFE $XBI
0 · Reply
framus_morrigan
framus_morrigan Aug. 6 at 8:33 PM
$PFE And one month later here we are ... about to face its weekly SMA200 again ... Weekly chart
0 · Reply
nimii
nimii Aug. 6 at 8:18 PM
$PFE 27 tomorrow
2 · Reply
EingeLTrade
EingeLTrade Aug. 6 at 8:05 PM
Two $PFE directors have each purchased $1M worth of shares, the largest insider buys in Pfizer's history 👀
2 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 6 at 8:05 PM
$PFE Albert you see what happens when leadership BUYS shares?
0 · Reply
dom04
dom04 Aug. 6 at 7:47 PM
$PFE breather? Or keeping up?
0 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 6 at 7:42 PM
$PFE 52 week high by EOY.
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 6 at 7:39 PM
1 · Reply
Wstb100
Wstb100 Aug. 6 at 7:17 PM
$PFE actually in the green for once.
0 · Reply
bikechain
bikechain Aug. 6 at 6:50 PM
$PFE What do you suppose the two Directors see, who each bought about $1M (filed yesterday)?
3 · Reply
marketlimit
marketlimit Aug. 6 at 6:26 PM
$PFE $21 soon… then $19… they have nothing make nothing do nothing and nothing happens. lol
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 6 at 6:23 PM
$PFE mom, our stock is broken
0 · Reply
AviRun2Moon
AviRun2Moon Aug. 6 at 5:55 PM
$PFE its always a middle finger…
0 · Reply
TraderDaKing
TraderDaKing Aug. 6 at 4:49 PM
$ELTP $PFE $JNJ $MRNA $LLY Who is doing a deal with Elite?? SequestOx (ELI-200) is an investigational, abuse-deterrent opioid product developed by Elite Pharmaceuticals containing a combination of oxycodone hydrochloride and sequestered naltrexone for managing moderate to severe pain. How SequestOx WorksNormal Use: Taken orally as intended, the opioid agonist (oxycodone) releases for pain relief while the antagonist (naltrexone) stays locked inside and passes through the body unreleased.Tampering: If the capsule or beads are crushed, chewed, or dissolved, the naltrexone releases.Blockade: The released naltrexone blocks the euphoric high of oxycodone by binding to brain receptors, which deters recreational abuse. https://elitepharma.com/ Roaring Kitty?
0 · Reply
Brice149
Brice149 Aug. 6 at 4:26 PM
$PFE Lots of good if you look for it. The 20 and the 200 day ma are both moving up. The 50 is bottoming and will start moving up next week. The 100 day ma is still in a down trend, but we are right at it today.
1 · Reply
HarryPopotter
HarryPopotter Aug. 6 at 4:07 PM
$PFE https://www.change.org/p/keep-hope-alive-approve-deramiocel-children-with-dmd-are-dying
1 · Reply
Brice149
Brice149 Aug. 6 at 4:05 PM
$PFE Woould be great to close above 25.92. Would love higher but that would be above the 100 day average and 200 day average.
1 · Reply
Brice149
Brice149 Aug. 6 at 4:00 PM
$PFE Sitting right at the 200 day m/a
1 · Reply